arrow
A

A. Pieter Kappetein

Erasmus University Rotterdam
H指数:106
被引数:7.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ten-year survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with Taxus and cardiac surgery randomized trial

经皮冠状动脉介入治疗与Taxus和心脏手术的协同作用下,外科手术与经皮血运重建的十年生存获益和适当性随机试验

2024-10-240
PRE
The ROMA trial: 7 years of trial activities and the development of the ROMA trial network
2024-05-161
PRE
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials
2024-04-236
OA
Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table

心血管医学的设备创新: 欧洲心脏病学会心血管圆桌会议的报告

2024-02-163
OA
Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes A Pooled Analysis of 4 Randomized Clinical Trials
2023-07-0111
OA
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization
2023-05-081
OAAI
Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization
2022-10-2513
OA
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease

经皮冠状动脉介入治疗或冠状动脉旁路移植术后残余心绞痛对复杂冠状动脉疾病长期临床结局的影响

2022-08-245
OAAI
Mortality after multivessel revascularisation involving the proximal left anterior descending artery

涉及左前降支近端动脉的多支血管血运重建后的死亡率

HEART
IF4.4
2022-06-228
OAAI
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Calcification
2022-01-0133
OAAI